Shin Maeda Selected Research

Pentetic Acid (DTPA)

6/2021	Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.
1/2021	The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma.
1/2020	Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation.
7/2018	Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
3/2013	Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.
1/2012	Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shin Maeda Research Topics

Disease

65	Neoplasms (Cancer) 03/2024 - 09/2004
59	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 03/2009
29	Carcinogenesis 01/2023 - 12/2003
29	Inflammation (Inflammations) 12/2022 - 09/2004
16	Stomach Neoplasms (Stomach Cancer) 04/2024 - 03/2002
13	Infections 01/2023 - 02/2002
12	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 01/2011
10	Hemorrhage 12/2024 - 01/2008
10	Adenocarcinoma 04/2024 - 01/2011
7	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 04/2009
7	Liver Neoplasms (Liver Cancer) 10/2021 - 07/2007
7	Fibrosis (Cirrhosis) 04/2021 - 01/2012
7	Neoplasm Metastasis (Metastasis) 06/2020 - 09/2004
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 09/2007
6	Liver Diseases (Liver Disease) 01/2021 - 01/2011
5	Necrosis 01/2022 - 08/2008
5	Chronic Hepatitis C 03/2021 - 11/2009
5	Colitis 05/2015 - 08/2007
4	Pathologic Constriction (Stenosis) 12/2024 - 03/2011
4	Diarrhea 06/2023 - 01/2020
4	Neutropenia 06/2023 - 01/2018
4	Ulcerative Colitis 01/2023 - 04/2011
4	Aberrant Crypt Foci 09/2014 - 01/2010
4	Non-alcoholic Fatty Liver Disease 11/2013 - 11/2011
4	Colitis-Associated Neoplasms 06/2010 - 08/2007
3	Thrombosis (Thrombus) 02/2021 - 01/2017
3	Hypersensitivity (Allergy) 02/2021 - 01/2011
3	Peptic Ulcer (Peptic Ulcers) 01/2018 - 07/2011
3	Colonic Neoplasms (Colon Cancer) 10/2015 - 09/2004
3	Gastritis 01/2013 - 02/2008
2	Abdominal Pain (Pain, Abdominal) 04/2024 - 01/2021
2	Esophageal Squamous Cell Carcinoma 03/2024 - 01/2023
2	Sarcopenia 10/2022 - 01/2022
2	Febrile Neutropenia 01/2022 - 01/2018
2	Anorexia 01/2022 - 01/2018
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 05/2020
2	Sclerosing Cholangitis 04/2021 - 01/2014
2	Polyps 04/2021 - 09/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

19	NF-kappa B (NF-kB)IBA 07/2010 - 09/2004
10	lenvatinibIBA 01/2022 - 01/2020
10	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 02/2012
10	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2010
8	Contrast MediaIBA 01/2022 - 10/2012
8	Mitogen-Activated Protein KinasesIBA 02/2014 - 03/2002
8	I-kappa B KinaseIBA 04/2009 - 02/2005
7	GadoliniumIBA 06/2021 - 01/2012
7	Phosphotransferases (Kinase)IBA 04/2012 - 07/2008
6	Therapeutic UsesIBA 10/2022 - 01/2013
6	Pentetic Acid (DTPA)FDA LinkGeneric 06/2021 - 01/2012
6	perfluorobutane (AI 700)IBA 01/2020 - 10/2012
6	CarcinogensIBA 12/2017 - 12/2003
6	Interleukin-6 (Interleukin 6)IBA 01/2013 - 07/2007
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011 - 09/2004
5	Leucovorin (Folinic Acid)FDA Link 03/2024 - 01/2018
5	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 01/2018
5	Insulin (Novolin)FDA Link 08/2021 - 02/2005
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2006
4	Bevacizumab (Avastin)FDA Link 03/2024 - 08/2021
4	atezolizumabIBA 03/2024 - 08/2021
4	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 01/2018
4	Gemcitabine FDA Link 11/2023 - 10/2019
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 10/2018
4	SonazoidIBA 06/2021 - 05/2017
4	Cadherins (E-Cadherin)IBA 04/2021 - 01/2014
4	Dextran SulfateIBA 05/2015 - 08/2007
4	Virulence Factors (Pathogenicity Factors)IBA 11/2012 - 02/2002
3	Peptides (Polypeptides)IBA 12/2024 - 09/2007
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 01/2018
3	Metronidazole (Metric)FDA LinkGeneric 08/2023 - 01/2017
3	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2020
3	130-nm albumin-bound paclitaxelIBA 10/2022 - 10/2019
3	EnzymesIBA 01/2022 - 02/2005
3	BilirubinIBA 02/2021 - 01/2020
3	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 02/2021 - 01/2017
3	SteroidsIBA 10/2018 - 04/2011
3	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2013 - 07/2008
3	CytokinesIBA 01/2013 - 01/2010
3	LigandsIBA 11/2011 - 08/2009
3	MAP Kinase Kinase Kinase 5IBA 07/2011 - 03/2010
3	AzoxymethaneIBA 03/2010 - 01/2009
3	SaltsIBA 10/2007 - 08/2007
2	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 03/2015
2	folfirinoxIBA 01/2022 - 01/2018
2	Epirubicin (Ellence)FDA LinkGeneric 06/2021 - 12/2017
2	Capsules (Microcapsules)IBA 04/2021 - 01/2013
2	SofosbuvirIBA 03/2021 - 12/2020

Therapy/Procedure

33	Therapeutics 04/2024 - 01/2011
17	Drug Therapy (Chemotherapy) 03/2024 - 11/2011
15	Radiofrequency Ablation 01/2022 - 03/2012
6	Stents 07/2021 - 01/2011
3	Surgical Instruments (Clip) 12/2024 - 02/2021
3	Ligation 01/2022 - 07/2002
3	Gastrostomy 07/2021 - 06/2013
3	Radiotherapy 03/2021 - 06/2013
2	Gastrectomy 04/2024 - 01/2023
2	Liver Transplantation 10/2021 - 03/2011
2	Microspheres (Microsphere) 06/2021 - 08/2015
2	Hepatectomy 02/2021 - 08/2011
2	Self Expandable Metallic Stents 02/2021 - 01/2015